Australia’s notifiable disease status, 2016: Annual report of the National Notifiable Diseases Surveillance System
DOI:
https://doi.org/10.33321/cdi.2021.45.28Keywords:
NNDSS, Notifiable diseases, AustraliaAbstract
In 2016, a total of 67 diseases and conditions were nationally notifiable in Australia. The states and territories reported 330,387 notifications of communicable diseases to the National Notifiable Diseases Surveillance System. Notifications have remained stable between 2015 and 2016. In 2016, the most frequently notified diseases were vaccine preventable diseases (139,687 notifications, 42% of total notifications); sexually transmissible infections (112,714 notifications, 34% of total notifications); and gastrointestinal diseases (49,885 notifications, 15% of total notifications). Additionally, there were 18,595 notifications of bloodborne diseases; 6,760 notifications of vectorborne diseases; 2,020 notifications of other bacterial infections; 725 notifications of zoonoses and one notification of a quarantinable disease.
Downloads
References
Australian Government Department of Health. National Health Security Act, 2007. Canberra: Australian Government Department of Health; 2007. Available from: https://www.legislation.gov.au/Details/C2016C00847.
Australian Government Department of Health. National Health Security (National Notifiable Disease List) Instrument 2018. Canberra: Australian Government Department of Health; 2018. Available from: https://www.legislation.gov.au/Details/F2020C00149.
Australian Government Department of Health. National Health Security Agreement. [internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-nhs-agreement.htm.
The Kirby Institute. Annual Surveillance Report on HIV, viral hepatitis and STIs in Australia 2017. [Internet.] Sydney: University of New South Wales, The Kirby Institute. Available from: https://kirby.unsw.edu.au/report/annual-surveillance-report-hiv-viral-hepatitis-and-stis-australia-2017.
Australian Government Department of Health. CJD: Surveillance of Creutzfeldt-Jakob disease in Australia. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-cjdanrep.htm.
Australian Government Department of Health. National Notifiable Diseases Surveillance System - current CDNA fortnightly report. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cdnareport.htm.
Australian Government Department of Health. Communicable Diseases Intelligence. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-cdi-cdicur.htm.
Australian Bureau of Statistics. 3101.0 - Australian Demographic Statistics, September 2019. [Internet.] Canberra: Australian Bureau of Statistics; 2019. Available from: https://www.abs.gov.au/ausstats/abs@.nsf/mf/3101.0.
Australian Institute of Health and Welfare (AIHW). Metadata online registry. Age-standardised rate - identifying and definitional attributes. [Internet.] Canberra: Australian Government, AIHW. Available from: https://meteor.aihw.gov.au/content/index.phtml/itemId/327276.
Graham S, Guy RJ, Donovan B, McManus H, Su JY, El-Hayek C et al. Epidemiology of chlamydia and gonorrhea among Indigenous and non-Indigenous Australians, 2000-2009. Med J Aust. 2012;197(11);642–6.
Hammerschlag MR. Sexually transmitted diseases in sexually abused children: medical and legal implications. Sex Transm Infect. 1998;74(3):167–74.
AIHW. Metadata online registry. Person - Indigenous status, code N; identifying and definitional attributes. [Internet.] Canberra: Australian Government, AIHW. Available from: https://meteor.aihw.gov.au/content/index.phtml/itemId/291036.
Australian Bureau of Statistics. 1269.0 - Standard Australian Classification of Countries (SACC), 2016. [Internet.] Canberra: Australian Bureau of Standards; 27 June 2016. Available from: https://www.abs.gov.au/AUSSTATS/abs@.nsf/mf/1269.0.
Chen MY, Fairley CK, Donovan B. Nowhere near the point of diminishing returns: correlations between chlamydia testing and notifications rates in New South Wales. Aust N Z J Public Health. 2005;29(3):249–53.
Hocking J, Fairley C, Counahan M, Crofts N. The pattern of notification and testing for genital Chlamydia trachomatis infection in Victoria, 1998-2000: an ecological analysis. Aust N Z J Public Health. 2003;27(4):405–8.
Burckhardt F, Warner P, Young H. What is the impact of change in diagnostic test method on surveillance data trends in Chlamydia trachomatis infection? Sex Transm Infect. 2006;82(1):24–30.
Chen MY, Karvelas M, Sundararajan V, Hocking JS, Fairley CK. Evidence for the effectiveness of a chlamydia awareness campaign: increased population rates of chlamydia testing and detection. Int J STD AIDS. 2007;18(4):239–43.
Ali H, Guy RJ, Fairley CK, Wand H, Chen MY, Dickson B et al. Understanding trends in genital Chlamydia trachomatis can benefit from enhanced surveillance: findings from Australia. Sex Transm Infect. 2012;88(7):552–7.
Stephens N, O’Sullivan M, Coleman D, Shaw K. Chlamydia trachomatis in Tasmania 2001-2007: rising notification trends. Aust N Z J Public Health. 2010;34(2):120–5.
Australian Government Department of Health. Australian national notifiable diseases and case definitions. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cdna-casedefinitions.htm.
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). National HBV testing policy. [Internet.] Sydney: ASHM. Available from: http://testingportal.ashm.org.au/hbv.
ASHM. National HCV testing policy. [Internet.] Sydney: ASHM. Available from: http://testingportal.ashm.org.au/hcv.
Heymann D. Control of Communicable Diseases Manual. 20th Edition. Washington DC: American Public Health Association; 2015.
National Centre for Immunisation Research and Surveillance (NCIRS). Significant events in hepatitis B vaccination practice in Australia. Sydney: NCIRS; July 2019. Available: http://ncirs.org.au/sites/default/files/2019-07/Hepatitis-B-history-July%202019.pdf.
Gidding HF, Warlow M, MacIntyre CR, Backhouse J, Gilbert GL, Quinn HE et al. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine. 2007;25(51):8637–41.
MacLachlan JH, Allard N, Towell V, Cowie BC. The burden of chronic hepatitis B virus infection in Australia, 2011. Aust N Z J Public Health. 2013;37(5):416–22.
Naidu L, Chiu C, Habig A, Lowbridge C, Jayasinghe S, Wang H et al. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 2006-2010. Commun Dis Intell Q Rep. 2013;37(Suppl):S1–S95.
Butler T, Simpson M. National Prison Entrants’ Bloodborne Virus and Risk Behaviour Survey Report: 2004, 2007, 2010, 2013 and 2016. Sydney: University of New South Wales, The Kirby Institute; 2017. Available from: https://kirby.unsw.edu.au/report/national-prison-entrants-bloodborne-virus-and-risk-behaviour-survey-report-2004-2007-2010.
Australian Government Department of Health. National Notifiable Diseases Surveillance System. [Internet.] Canberra: Australian Government Department of Health. Available from: http://www9.health.gov.au/cda/source/cda-index.cfm.
Australian Government Department of Health. OzFoodNet Reports. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cdna-ozfoodnet-reports.htm.
OzFoodNet Working Group. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: Annual report of the OzFoodNet Network, 2010. Commun Dis Intell Q Rep. 2012;36(3):E213–41.
NCIRS. Significant events in hepatitis A vaccination practice in Australia. Sydney: NCIRS; December 2018. Available from: http://www.ncirs.org.au/sites/default/files/2018-12/Hepatitis-A-history-Dec-2018.pdf.
OzFoodNet Working Group. Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: annual report of the OzFoodNet Network, 2009. Commun Dis Intell Q Rep. 2010;34(4):396–426.
Lamont RF, Sobel J, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, Kim SK et al. Listeriosis in human pregnancy: a systematic review. J Perinat Med. 2011;39(3):227–36.
NNDSS Annual Report Working Group. Australia’s notifiable diseases status, 2015: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell (2018). 2019;43. doi: https://doi.org/10.33321/cdi.2019.43.6.
van den Beld MJC, Reubsaet FAG. Differentiation between Shigella, enteroinvasive Escherichia coli (EIEC) and noninvasive Escherichia coli. Eur J Clin Microbiol Infect Dis. 2012;31(6):899–904.
Australian Government Department of Health. Shiga toxin-producing Escherichia coli (STEC) case definition. [Internet.] Canberra: Australian Government Department of Health, Communicable Diseases Network Australia; 23 August 2016. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_stec.htm.
Australian Government Department of Health. Haemolytic uraemic syndrome (HUS) case definition. [Internet.] Canberra: Australian Government Department of Health, Communicable Diseases Network Australia; 12 March 2004. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_hus.htm.
Cumpston JHL. Health and disease in Australia: a history. Canberra: Australian Government Publishing Service; 1989.
Grattan-Smith PJ, O’Regan WJ, Ellis PS, O’Flaherty SJ, McIntyre PB, Barnes CJ. Rabies. A second Australian case, with a long incubation period. Med J Aust. 1992;156(9):651–4.
Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. Geneva: WHO; 1988. Available from: https://apps.who.int/iris/handle/10665/39485.
Australian Government Department of Health and Ageing. Guidelines for Smallpox Outbreak, Preparedness, Response and Management. [Internet.] Canberra: Australian Government Department of Health and Ageing; January 2004. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/health-pubhlth-strateg-bio-agents.htm.
NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2013: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell Q Rep. 2015;39(3):E387–478.
Miller M, Roche P, Yohannes K, Spencer J, Bartlett M, Brotherton J et al. Australia’s notifiable disease status, 2003: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell Q Rep. 2005;29(1):1–61.
World Health Organization (WHO). Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. [Internet.] Geneva: WHO; 2020. Available from: https://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/.
Curran M, Harvey B, Crerar S, Oliver G, D’Souza R, Myint H et al. Annual report of the National Notifiable Diseases Surveillance System, 1996. Commun Dis Intell. 1997;21(20):281–307.
Forssman B, Mannes T, Musto J, Gottlieb T, Robertson G, Natoli JD et al. Vibrio cholerae O1 EI Tor cluster in Sydney linked to imported whitebait. Med J Aust. 2007;187(6):345–7.
Geisler WM, Lensing SY, Press CG, Hook EW. Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. J Infect Dis. 2013;207(12):1850–6.
Victorian Department of Health and Human Services (DHHS). Disease information and advice: donovanosis. [Internet.] Melbourne: Victoria State Government, DHHS. Available from: https://www2.health.vic.gov.au/public-health/infectious-diseases/disease-information-advice/donovanosis.
Australasian Sexual Health Alliance (ASHA). Australian STI management guidelines for use in primary care. [Internet.] Sydney: Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine; 2018. Available from: http://www.sti.guidelines.org.au/sexually-transmissible-infections/donovanosis.
Bowden FJ, National Donovanosis Eradication Advisory Committee. Donovanosis in Australia: going, going. Sex Transm Infect. 2005;81(5):365–6.
DHHS. Disease information and advice: gonorrhoea. [Internet.] Melbourne: Victoria State Government, DHHS. Available from: https://www2.health.vic.gov.au/public-health/infectious-diseases/disease-information-advice/gonorrhoea.
Donovan B, Dimech W, Ali H, Guy R, Hellard M. Increased testing for Neisseria gonorrhoeae with duplex nucleic acid amplification tests in Australia: implications for surveillance. Sex Health. 2015;12(1):48–50.
Roberts-Witteveen A, Pennington K, Higgins N, Lang C, Lahra M, Waddell R et al. Epidemiology of gonorrhoea notifications in Australia, 2007-12. Sex Health. 2014;11(4):324–31.
Australian Government Department of Health. Gonococcal: Australian Gonococcal Surveillance Programme annual reports. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-annlrpt-gonoanrep.htm.
Australian Government Department of Health. Syphilis - infectious (primary, secondary and early latent), less than 2 years duration case definition. [Internet.] Canberra: Australian Government Department of Health; 1 July 2015. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_syphl2.htm.
Australian Government Department of Health. Infectious syphilis outbreak. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-infectious-syphilis-outbreak.htm.
DHHS. Syphilis cases continue to rise in Victoria. [Internet.] Melbourne: Victoria State Government, DHHS; 25 March 2019. Available from: https://www2.health.vic.gov.au/about/news-and-events/healthalerts/rising-syphilis-cases-august-2018.
Ward JS, Guy RJ, Akre SP, Middleton MG, Giele CM, Su JY et al. Epidemiology of syphilis in Australia: moving toward elimination of infectious syphilis from Aboriginal and Torres Strait Islander communities? Med J Aust. 2011;194(10):525–9.
Australian Government Department of Health. Fifth National Aboriginal and Torres Strait Islander BBV and STI Strategy 2018–2022. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-bbvs-1.
Australian Government Department of Health. Fourth National STI Strategy 2018–2022. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-bbvs-1.
Australian Government Department of Health. National Immunisation Program. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www.health.gov.au/initiatives-and-programs/national-immunisation-program.
Centers for Disease Control and Prevention (CDC). Impact of vaccines universally recommended for children—United States, 1900–1998. JAMA. 1999;281(16):1482–3.
Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86(2):140–6.
Ehreth J. The global value of vaccination. Vaccine. 2003;21(7–8):596–600.
Préziosi MP, Halloran ME. Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. Clin Infect Dis. 2003;37(6):772–9.
NCIRS. Haemophilus influenzae type b (Hib) vaccines for Australian children. [Internet.] Sydney: NCIRS; June 2018. Available from: http://www.ncirs.org.au/ncirs-fact-sheets-faqs/haemophilus-influenzae-type-b-hib-vaccines-australian.
Australian Government Department of Health. Australian Immunisation Handbook. [Internet.] Canberra: Australian Government Department of Health. Available from: https://immunisationhandbook.health.gov.au/.
Chandran A, Watt JP, Santosham M. 13 - Haemophilus influenzae vaccines. In Plotkin S, Orenstein W, Offit P, eds. Vaccines. (Sixth edition.) Philadelphia: Saunders / Elsevier, 2012;167–82.
Punpanich W, Chotpitayasunondh T. A review on the clinical spectrum and natural history of human influenza. Int J Infect Dis. 2012;16(10):E714–23.
Carrat F, Vergu E, Ferguson NM, M. Lemaitre M, Cauchemez S, Leach S et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167(7):775–85.
Mauskopf J, Klesse M, Lee S, Herrera-Taracena G. The burden of influenza complications in different high-risk groups: a targeted literature review. J Med Econ. 2013;16(2):264–77.
Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. (Eighth edition.) Amsterdam: Elsevier Health Sciences, 2014.
WHO Collaborating Centre for Reference and Research on Influenza (VIDRL). Annual Reports. [Internet.] Melbourne: Peter Doherty Institute for Infection and Immunity, VIDRL. Available from: http://www.influenzacentre.org/centre_reports.htm.
Australian Government Department of Health. Australian influenza surveillance report and activity updates. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-ozflu-flucurr.htm#nat-scheme.
Atkinson W, Wolfe CS, Hamborsky J. Epidemiology and prevention of vaccine preventable diseases. (Twelfth edition.) Washington DC: Public Health Foundation, 2011.
WHO. Fact sheets. Measles. [Internet.] Geneva: WHO; 2019. Available from: https://www.who.int/news-room/fact-sheets/detail/measles.
Strebel PM, Papania MJ, Gastañaduy PA, Goodson JL. 37 - Measles Vaccines. In Plotkin S, Orenstein W, Offit P, Edwards KM, eds. Plotkin’s Vaccines. (Seventh edition). Philadelphia: Saunders / Elsevier, 2018;579–618.
Gidding HF, Wood J, MacIntyre CR, Kelly H, Lambert SB, Gilbert GL et al. Sustained measles elimination in Australia and priorities for long-term maintenance. Vaccine. 2007;25(18):3574–80.
Heywood AE, Gidding HF, Riddell MA, McIntyre PB, MacIntyre CR, Kelly HA. Elimination of endemic measles transmission in Australia. Bull World Health Organ. 2009;87(1):64–71.
WHO. Four Western Pacific countries and areas are the first in their Region to be measles-free. [Internet.] Geneva: WHO; 20 March 2014. Available from: https://www.who.int/westernpacific/news/detail/20-03-2014-four-western-pacific-countries-and-areas-are-the-first-in-their-region-to-be-measles-free.
Gidding HF, Martin NV, Stambos V, Tran T, Dey A, Dowse GK et al. Verification of measles elimination in Australia: Application of World Health Organization regional guidelines. J Epidemiol Glob Health. 2016;6(3):197–209.
Plotkin SA, Rubin SA. Chapter 20 - Mumps vaccine. In Plotkin S, Orenstein W, Offit P, eds. Vaccines. (Fifth edition). Philadelphia: Saunders / Elsevier, 2008;435–65.
Westphal DW, Eastwood A, Levy A, Davies J, Huppatz C, Gilles M et al. A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study. Lancet Infect Dis. 2019;19(2):177–84.
Bangor-Jones RD, Dowse GK, Giele CM, van Buynder PG, Hodge MM, Whitty MM. A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia. Med J Aust. 2009;191(7):398–401.
Deeks SL, Lim GH, Simpson MA, Gagné L, Kristjanson E, Fung C et al. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ. 2011;183(9):1014–20.
Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev. 2012;2012(2)CD004407.
Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005.BMJ. 2005;330(7500):1132–5.
Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JMH et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358(15):1580–9.
Whelan J, van Binnendijk R, Greenland K, Fanoy E, Khargi M, Yap K et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill. 2010;15(17):19554.
Cohen C, White JM, E. Savage EJ, J. Glynn JR, Y. Choi Y, N. Andrews N et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis. 2007;13(1):12–17.
Australian Government Department of Health. National Immunisation Program Schedule. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www.health.gov.au/health-topics/immunisation/immunisation-throughout-life/national-immunisation-program-schedule.
NCIRS. Pertussis vaccines for Australians. [Internet.] Sydney: NCIRS; June 2019. Available from: http://ncirs.org.au/ncirs-fact-sheets-faqs/pertussis-vaccines-australians.
Quinn HE, Snelling TL, Macartney KK, McIntyre PB. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics. 2014;133(3):E513–9.
Sheridan SL, McCall BJ, Davis CA, Robson JMB, Hull BP, Selvey CE et al. Acellular pertussis vaccine effectiveness for children during the 2009-2010 pertussis epidemic in Queensland. Med J Aust. 2014;200(6):334–8.
Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5 Suppl):S58–61.
Munoz FM. Pertussis in infants, children and adolescents: diagnosis, treatment, and prevention. Semin Pediatr Infect Dis. 2006;17(1):14–19.
Australian Government Department of Health. Pertussis. CDNA National Guidelines for Public Health Units. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-pertussis.htm.
NCIRS. Significant events in pneumococcal vaccination practice in Australia. Sydney: NCIRS; June 2018. Available from: http://ncirs.org.au/sites/default/files/2019-09/Pneumococcal-history-July-2019.pdf.
NCIRS. Pneumococcal vaccines for Australians. [Internet.] Sydney: NCIRS; July 2020. Available from: http://ncirs.org.au/ncirs-fact-sheets-faqs/pneumococcal-vaccines-australians.
Australian Government Department of Health. National Notifiable Diseases Surveillance System. Pneumococcal disease (invasive) Public dataset. [Internet.] Canberra: Australian Government Department of Health. Available from: http://www9.health.gov.au/cda/source/pub_pneum.cfm.
Australian Government Department of Health. Invasive Pneumococcal Disease Surveillance. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-ipd-reports.htm.
WHO. WHO-recommended surveillance standard of poliomyelitis. [Internet.] Geneva: WHO. Available from: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/poliomyelitis_standards/en/.
Australian Government Department of Health. Polio - Australian National Enterovirus Reference Laboratory annual reports. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/content/cda-pubs-annlrpt-polioanrep.htm.
Global Polio Eradication Initiative (GPEI). Polio Eradication and Endgame Strategic Plan 2013–2018. [Internet.] Geneva: WHO, GPEI. Available from: http://polioeradication.org/who-we-are/strategic-plan-2013-2018/.
Khan F, Deblina Datta S, Quddus A, VertefeuilleJF, Burns CC, Jorba J et al. Progress toward polio eradication — worldwide, January 2016 – March 2018. MMWR Morb Mortal Wkly Rep. 2018;67(18):524–8.
GPEI. Global eradication of wild poliovirus type 2 declared. [Internet.] Geneva: WHO, GPEI; 20 September 2015. Available from: http://polioeradication.org/news-post/global-eradication-of-wild-poliovirus-type-2-declared/.
Ramirez Gonzalez A, Farrell M, Menning L, Garon J, Everts H, Hampton LM et al. Implementing the synchronized global switch from trivalent to bivalent oral polio vaccines—lessons learned From the global perspective. J Infect Dis. 2017;216(suppl 1):S183–92.
McLean H, Redd S, Abernathy E, Icenogle J, Wallace G. Chapter 15: Congenital rubella syndrome. In Roush SW, Baldy LM, Kirkconnell Hall MA, eds. Manual for the Surveillance of Vaccine Preventable Diseases. Atlanta: Centers for Disease Control and Prevention, 2012.
Song N, Gao Z, Wood JG, Hueston L, Gilbert GL, MacIntyre CR et al. Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination. Vaccine. 2012;30(27):4073–8.
WHO: Western Pacific Regional Office. Rubella and congenital rubella syndrome. Geneva: WHO; 2012.
Khandaker G, Zyrynski Y, Jones C. Surveillance for congenital rubella syndrome in Australia since 1993: cases reported between 2004 and 2013. Vaccine. 2014;32(50):6746–51.
Quinn HE, McIntyre PB. Tetanus in the elderly – an important preventable disease in Australia. Vaccine. 2007;25(7):1304–9.
NCIRS. Significant events in diphtheria, tetanus and pertussis vaccination practice in Australia. Sydney: NCIRS; July 2018. Available from: http://www.ncirs.org.au/sites/default/files/2018-11/Diphtheria-tetanus-pertussis-history-July-2018.pdf.
NCIRS. Significant events in varicella vaccination practice in Australia. Sydney: NCIRS; July 2018. Available from: http://www.ncirs.org.au/sites/default/files/2018-11/Varicella-history-July-2018.pdf.
NCIRS. Significant events in zoster vaccination practice in Australia. Sydney: NCIRS; December 2018. Available from: http://www.ncirs.org.au/sites/default/files/2018-12/Zoster-history-Dec-2018.pdf.
Australian Government Department of Health. NAMAC Committee overview. [Internet.] Canberra: Australian Government Department of Health; November 2010. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/health-arbovirus-namac-overview.htm.
Australian Government Department of Health. Australian Health Protection Principal Committee (AHPPC). [Internet.] Canberra: Australian Government Department of Health. Available from: https://www.health.gov.au/committees-and-groups/australian-health-protection-principal-committee-ahppc.
Mackenzie JS, Lindsay MD, Coelen RJ, Broom AK, Hall RA, Smith DW. Arboviruses causing human disease in the Australasian zoogeographic region. Arch Virol. 1994;136(3–4):447–6.
Russell RC, Dwyer DE. Arboviruses associated with human disease in Australia. Microbes Infect. 2000;2(14):1693–704.
Australian Government Department of Health. Barmah Forest virus infection case definition. [Internet.] Canberra: Australian Government Department of Health; 1 January 2016. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_bfv.htm.
Therapeutic Goods Administration (TGA). Product Recall: RC-2013-RN-00967-1. Panbio Barmah Forest Virus IgM ELISA. An in vitro diagnostic medical device (IVD). [Internet.] Canberra: Australian Government Department of Health, TGA; 13 September 2013. Available from: https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2013-RN-00967-1.
Parida MM, Santhosh SR, Dash PK, Lakshmana Rao PV. Rapid and real-time assays for detection and quantification of chikungunya virus. Future Virol. 2008;3(2). doi: https://doi.org/10.2217/17460794.3.2.179.
Harrington S, Lindsay M, Douglas A. Christmas Island and Cocos (Keeling) Islands, Indian Ocean: Mosquito fauna and mosquito-borne disease risk assessment and management recommendations. Final report of investigations undertaken in 2007–08. Perth: Western Australian Government Department of Health, Public Health Division; 2009.
WHO. Dengue and severe dengue. [Internet.] Geneva: WHO; 23 June 2030. Available from: https://www.who.int/en/news-room/fact-sheets/detail/dengue-and-severe-dengue.
Guzmán MG, Kourí G, Martínez E, Bravo J, Riverón R, Soler M et al. Clinical and serological study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Bull Pan Am Health Organ. 1987;21(3):270–9.
Mackenzie JS, Gubler DJ, Petersen LR. Emerging flavivruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med. 2004;10(12 Suppl):S98–S109.
Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181(1):2–9.
Queensland Health. Queensland Dengue Management Plan 2015–2020. Brisbane: Queensland Government Department of Health, Communicable Diseases Branch; 2015.
Knope KE, Muller M, Kurucz N, Doggett SL, Feldman R, Johansen CA et al. Arboviral diseases and malaria in Australia, 2013-14: annual report of the National Arbovirus and Malaria Advisory Committee. Commun Dis Intell Q Rep. 2016;40(3):E400–36.
Whelan P, Nguyen H, Hajkowicz K, Davis J, Smith D, Pyke A et al. Evidence in Australia for a case of airport dengue. PLoS Negl Trop Dis. 2012;6(9):e1619.
Lindsay MDA, Jardine A, Giele C, Armstrong P, McCarthy S, Whittle A et al. Investigation of the first case of dengue virus infection acquired in Western Australia in seven decades: evidence of importation of infected mosquitoes? PLoS Negl Trop Dis. 2015;9(9):e0004114.
Knope K, National Arbovirus and Malaria Advisory Committee, Giele C. Increasing notifications of dengue related to overseas travel, 1991 to 2012. Commun Dis Intell Q Rep. 2013;37(1):E55–9.
Australian Government Department of Health. Flavivirus infection (unspecified) including Zika virus case definition. [Internet.] Canberra: Australian Government Department of Health; 15 April 2016. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_flavnec.htm.
Musso D, Roche C, Robin E, Nhan T, Teissier A, Cao-Lormeau VM. Potential sexual transmission of Zika virus. Emerg Infect Dis. 2015;21(2):359–61.
Cardoso CW, Paploski IAD, Kikuti M, Rodrigues MS, Silva MMO, Campos GS et al. Outbreak of exanthematous illness associated with Zika, chikungunya, and dengue viruses, Salvador, Brazil. Emerg Infect Dis. 2015;21(12):2274–6.
Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531–9.
Paploski IAD, Prates APPB, Cardoso CW, Kikuti M, Silva MMO, Waller LA et al. Time lags between exanthematous illness attributed to Zika virus, Guillain-Barré syndrome, and microcephaly, Salvador, Brazil. Emerg Infect Dis. 2016;22(8):1438–44.
WHO. WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations. [Internet.] Geneva: WHO; 1 February 2016. Available from: https://www.who.int/en/news-room/detail/01-02-2016-who-statement-on-the-first-meeting-of-the-international-health-regulations-(2005)-(ihr-2005)-emergency-committee-on-zika-virus-and-observed-increase-in-neurological-disorders-and-neonatal-malformations.
Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects--reviewing the evidence for causality. N Engl J Med. 2016;374(20):1981–7.
McCarthy M. Zika virus was transmitted by sexual contact in Texas, health officials report. BMJ. 2016;352. doi: https://doi.org/10.1136/bmj.i720.
Foy BD, Kobylinski KC, Chilson Foy JL, Blitvich BJ, Travassos da Rosa A, Haddow AD et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis. 2011;17(5):880–2.
Atkinson B, Hearn P, Afrough B, Lumley S, Carter D, Aarons EJ et al. Detection of Zika virus in semen. Emerg Infect Dis. 2016;22(5):940.
Deckard DT, Chung WM, Brooks JT, Smith JC, Woldai S, Hennessey M et al. Male-to-male sexual transmission of Zika virus – Texas, January, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(14):372–4.
Davidson A, Slavinski S, Komoto K, Rakeman J, Weiss D. Suspected female-to-male sexual transmission of Zika virus – New York City, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(28):716–7.
Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, van den Hurk AF et al. Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust. 1999;170(11):533–6.
WHO. Fact sheets. West Nile Virus. Geneva: WHO; 3 October 2017. Available from: https://www.who.int/news-room/fact-sheets/detail/west-nile-virus.
Prow NA. The changing epidemiology of Kunjin virus in Australia. Int J Environ Res Public Health. 2013;10(12):6255–72.
Cox-Singh J, Davis TME, Lee KS, Shamsul SSG, Matusop A, Ratnam S et al.Plasmodium knowlesimalaria in humans is widely distributed and potentially life threatening. Clin Infect Dis. 2008;46(2):165–71.
Gray TJ, Trauer JM, Fairley M, Krause VL, Markey PG. Imported malaria in the Northern Territory, Australia – 428 consecutive cases. Commun Dis Intell Q Rep. 2012;36(1):107–13.
Hanna JN, Ritchie SA, Eisen DP, Cooper RD, Brookes DL, Montgomery BL. An outbreak ofPlasmodium vivaxmalaria in Far North Queensland, 2002. Med J Aust. 2004;180(1):24–8.
WHO. Key points: World malaria report 2017. [Internet.] Geneva: WHO; 29 November 2017. Available from: https://www.who.int/malaria/media/world-malaria-report-2017/en/#Global%20and%20regional%20malaria%20trends%20in%20numbers.
Mackenzie JS, Lindsay MDA, Smith DW, Imrie A. The ecology and epidemiology of Ross River and Murray Valley encephalitis viruses in Western Australia: examples of One Health in Action. Trans R Soc Trop Med Hyg. 2017;111(6):248–54.
Knope K, Whelan P, Smith D, Johansen C, Moran R, Doggett S et al. Arboviral diseases and malaria in Australia, 2010-11: annual report of the National Arbovirus and Malaria Advisory Committee. Commun Dis Intell Q Rep. 2013;31(1):E1–E20.
Australian Government Department of Health. Ross River virus infection case definition. [Internet.] Canberra: Australian Government Department of Health; 1 January 2016. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_rrv.htm.
Jansen CC, Shivas MA, May FJ, Pyke AT, Onn MB, Lodo K et al. Epidemiologic, entomologic, and virologic factors of the 2014-15 Ross River virus outbreak, Queensland, Australia. Emerg Infect Dis. 2019;25(12):2243–52.
Doggett S, Haniotis J, Clancy J, Webb C, Toi C, Hueston L et al. The New South Wales Arbovirus Surveillance and Mosquito Monitoring Program: 2016-2017 Annual Report. Sydney: New South Wales Government Department of Health, Pathology. Available from: https://www.health.nsw.gov.au/environment/pests/vector/Publications/nswasp-annual-report-2016-2017.pdf.
Koolhof IS, Gibney KB, Bettiol S, Charleston M, Wiethoelter A, Arnold AL et al. The forecasting of dynamical Ross River virus outbreaks: Victoria, Australia. Epidemics. 2020;30. doi: https://doi.org/10.1016/j.epidem.2019.100377.
WHO. Technical report series no 169. Joint WHO/FAO expert committee on zoonoses. Second report. Geneva: WHO; 1959.
Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Glitteman JL et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990–3.
Woolhouse MEJ, Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerg Infect Dis. 2005;11(12):1842–7.
WHO. Report of the WHO/FAO/OIE joint consultation on emerging zoonotic diseases / in collaboration with the Health Council of the Netherlands. Geneva: WHO; 2004. Available from: https://apps.who.int/iris/handle/10665/68899.
WHO. Anthrax in humans and animals. Fourth edition. Geneva: WHO; 2008. Available from: https://www.who.int/csr/resources/publications/AnthraxGuidelines2008/en/.
Animal Health Australia. Animal Health in Australia 2015. Canberra: Animal Health Australia; 2016.
Kolbe A, Yuen MG, Doyle BK. A case of human cutaneous anthrax. Med J Aust. 2006;185(5):281–2.
Fielding J. Zoonoses: anthrax. Vic Infect Dis Bull. 2007;10(2):47.
Communicable Diseases Branch, NSW Department of Health. Communicable Diseases Report, NSW, January and February 2010. N S W Public Health Bull. 2010;21(3-4):103–7.
Calisher CH, Ellison JA. The other rabies viruses: The emergence and importance of lyssaviruses from bats and other vertebrates. Travel Med Infect Dis. 2012;10(2):69–79.
Fraser GC, Hooper PT, Lunt RA, Gould AR, Gleeson LJ, Hyatt AD et al. Encephalitis caused by a lyssavirus in fruit bats in Australia. Emerg Infect Dis. 1996;2(4):327–31.
Hooper PT, Lunt RA, Gould AR, Samaratunga H, Hyatt AD, Gleeson LJ et al. A new lyssavirus – the first endemic rabies-related virus recognized in Australia. Bull Inst Pasteur. 1997;95(4):209–18.
Australian Government Department of Health. Rabies Virus and Other Lyssavirus (Including Australian Bat Lyssavirus) Exposures and Infections. CDNA National Guidelines for Public Health Units. [Internet.] Canberra: Australian Government Department of Health; 23 May 2018. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-abvl-rabies.htm.
Allworth A, Murray K, Morgan J. A human case of encephalitis due to a lyssavirus recently identified in fruit bats. Commun Dis Intell. 1996;20(24):504.
Hanna JN, Carney IK, Smith GA, Tannenberg AE, Deverill JE, Botha JA et al. Australian bat lyssavirus infection: a second human cases, with long incubation period. Med J Aust. 2000;172(12):597–9.
Francis JR, Nourse C, Vaska VL, Calvert S, Northill JA, McCall B et al. Australian bat lyssavirus in a child: the first reported case. Pediatrics. 2014;133(4):E1063–7.
Queensland Government Department of Agriculture. Australian bat lyssavirus overview. In: Animal Health and Diseases. Brisbane: Queensland Government Department of Agriculture; 2013.
Symons R. Australian bat lyssavirus update communiqué. Queensland Government Department of Agriculture, Fisheries and Forestry; 7 June 2013. Available from: https://www.ava.com.au/siteassets/about-us/divisions--branches/lyssavirus-communique-130607.pdf
Wildlife Health Australia. Bat health focus group. [Internet.] Sydney: Wildlife Health Australia. Available from: https://wildlifehealthaustralia.com.au/ProgramsProjects/BatHealthFocusGroup.aspx.
Wildlife Health Australia. ABLV bat stats. Australian bat lyssavirus report, December 2016. Sydney: Wildlife Health Australia. Available from: https://wildlifehealthaustralia.com.au/Portals/0/Documents/ProgramProjects/ABLV_Bat_Stats_Dec_2016.pdf.
Animal Health Australia. Animal Health in Australia 2012. Canberra: Animal Health Australia; 2013.
Eales KM, Norton RE, Ketheesan N. Brucellosis in northern Australia. Am J Trop Med Hyg. 2010;83(4):876–8.
Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14(2):296–326.
WHO. Human leptospirosis: guidance for diagnosis, surveillance and control. Geneva: WHO; 2002. Available from: https://apps.who.int/iris/handle/10665/42667.
Beeckman DSA, Vanrompay DCG. Zoonotic Chlamydophila psittaci infection from a clinical perspective. Clin Microbiol Infect. 2009;15(1):11–17.
Deschuyffeleer TPG, Tyberghien LFV, Dickx VLC, Geens T, Saelen JMMM, Vanrompay DCG et al. Risk assessment and management of Chlamydia psittaci in poultry processing plants.Ann Occup Hyg. 2012;56(3):340–9.
McCaul TF, Williams J. Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol. 1981;147(3):1063–76.
Lowbridge CP, Tobin S, Seale H, Ferson M. EpiReview: notifications of Q fever in NSW, 2001–2010. N S W Public Health Bull. 2012;23(12):31–5.
Bell M, Patel M, Sheridan J. Q fever vaccination in Queensland abattoirs. Commun Dis Intell. 1997;21(3):29–31.
Lin M, Delpech V, McAnulty J, Campbell-Lloyd S. Notifications of Q fever in New South Wales, 1991–2000: EpiReview. N S W Public Health Bull. 2001;12(6):172–5.
Gidding HF, Wallace C, Lawrence GL, McIntyre PB. Australia’s national Q fever vaccination program. Vaccine. 2009;27(14):2037–41.
Ellis J, Oyston PCF, Green M, Titball RW. Tularemia. Clin Microbiol Rev. 15(4):631–46.
Jackson J, McGregor A, Cooley L, Ng J, Brown M, Ong CW et al. Francisella tularensis subspecies holarctica, Tasmania, Australia, 2011. Emerg Infect Dis. 2012;18(9):1484–6.
Veitch M. The public health response to tularemia in Tasmania. [Conference presentation.] Communicable Disease Control Conference, Canberra; 19–20 March 2013.
NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2011: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell Q Rep. 2013;37(4):E313–93.
de Jong B, Zucs P. Legionella, springtime and potting soils. Euro Surveill. 2010;15(8):19497.
O’Connor BA, Carman J, Eckert K, Tucker G, Givney R, Cameron S. Does potting mix make you sick? Results for a Legionella longbeachae case-control study in South Australia. Epidemiol Infect. 2007;135(1):34–9.
Whiley H, Bentham R. Legionella longbeachae and legionellosis. Emerg Infect Dis. 2011;17(4):579–83.
Pravinkumar SJ, Edwards G, Lindsay D, Redmond S, Stirling J, House R et al. A cluster of legionnaire’s disease caused by Legionella longbeachae linked to potting compost in Scotland, 2008–2009. Euro Surveill. 2010;15(8):19496.
Li JS, O’Brien ED, Guest C. A review of national legionellosis surveillance in Australia, 1991 to 2000. Commun Dis Intell Q Rep. 2002;26(3):462–70.
Rota MC, Caporali MG, Bella A, Ricci ML, Napoli C. Legionnaires’ disease in Italy: results of the epidemiological surveillance from 2000 to 2011. Euro Surveill. 2013;18(23):20497.
WHO. Fact sheets: Leprosy. [Internet.] Geneva: WHO; 10 September 2019. Available from: https://www.who.int/news-room/fact-sheets/detail/leprosy.
Australian Government Department of Health. Invasive Meningococcal Disease. CDNA National Guidelines for Public Health Units. [Internet.] Canberra: Australian Government Department of Health; 4 July 2017. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-IMD.htm.
Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C, Durrheim D, Eskola J et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr. 2013;11(1):17.
Australian Government Department of Health. Meningococcal disease (invasive) surveillance case definition - V1.4. [Internet.] Canberra: Australian Government Department of Health; 19 January 2010. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_mening.htm.
NNDSS Annual Report Working Group. Australia’s notifiable disease status, 2014: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell Q Rep. 2016;40(1):E48–145.
National Centre for Immunisation Research and Surveillance. Significant events in meningococcal vaccination practice in Australia. Sydney: NCIRS; March 2020. Available from: http://ncirs.org.au/sites/default/files/2020-03/Meningococcal-history-Mar%202020.pdf.
Australian Government Department of Health. Meningococcal - Australian Meningococcal Surveillance Programme annual reports. [Internet.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-annlrpt-menganrep.htm.
Martin NV, Ong KS, Howden BP, Lahra MM, Lambert SB, Beard FH et al. Rise in invasive serogroup W meningococcal disease in Australia, 2013-2015. Commun Dis Intell Q Rep. 2016;40(4):E454–9.
Bareja C, Waring J, Stapledon R, National Tuberculosis Advisory Committee for the Communicable Diseases Network Australia. Tuberculosis notifications in Australia, 2010. Commun Dis Intell Q Rep. 2014;38(1):E36–48.
Luca S, Mihaescu T. History of BCG Vaccine. Maedica (Buchar). 2013;8(1):53–8.
Public Health England, Tuberculosis: the green book, chapter 32. In Immunisation against infectious disease. London: United Kingdom Department of Health; 2013. Available from: https://www.gov.uk/government/publications/tuberculosis-the-green-book-chapter-32.
National Tuberculosis Advisory Committee. The BCG vaccine: Information and recommendations for use in Australia. Commun Dis Intell Q Rep. 2013;37(1):E65–72.
Australian Government Department of Health. Tuberculosis notifications in Australia annual reports. [Online.] Canberra: Australian Government Department of Health. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-annlrpt-tbannrep.htm.
Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9(6)e0003832. doi: https://doi.org/10.1371/journal.pntd.0003832
Published
How to Cite
License
Copyright (c) 2021 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
